There are 133 resources available
Debate: GE Junction Tumors: Neoadjuvant Chemoradiotherapy (CRT) or Perioperative Chemotherapy (CT) - PRO CT
Presenter: Salah-Eddin Al-Batran, Germany
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
RATIONALE-306: Randomized, global, Phase 3 study of tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for locally advanced unresectable or metastatic esophageal squamous cell carcinoma (ESCC)
Presenter: Harry Yoon, United States
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Challenges with PDL Testing in Upper GI Cancer
Presenter: Magali Svrcek, France
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Checkpoint Inhibition in Esophageal Cancer
Presenter: Yelena Janjigian, United States
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Checkpoint Inhibition in Gastric Cancer
Presenter: Kei Muro, Japan
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
New Targets and Agents in Upper GI Cancer
Presenter: Florian Lordick, Germany
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Endoscopic Management of Early Esophageal and Gastric Cancer
Presenter: Raf Bisschops, Belgium
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Pathogenesis and Subtypes of HCC
Presenter: Josep Llovet, Spain
Session: Session IX: Hepatocellular Cancer
Resources:
Slides
Diagnostic and Imaging Challenges in HCC
Presenter: Vincent Vandecaveye, Belgium
Session: Session IX: Hepatocellular Cancer
Resources:
Slides
Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study
Presenter: Arndt Vogel, Germany
Session: Session IX: Hepatocellular Cancer
Resources:
Slides